Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

View:
Post by chry200030 on Oct 02, 2023 7:58pm

It's Time

I would load up at these prices. We know these won't last..
We are on the verge of some serious upticks..
Comment by Lesalpes29 on Oct 03, 2023 8:19am
Markets are weak and we follow. Next PP if needed could be around .20 without BTD shortly. I keep the focus on the destination during this bumpy time! GL
Comment by StevenBirch on Oct 03, 2023 9:39am
The stock closes at $0.20 and there's 65K bid at $0.21 today, if that doesn't tell you there are games being played nothing will. 
Comment by bigkagan on Oct 03, 2023 1:04pm
I bought a few shares today on the glioma news - the fact that their drug gets absorbed by the brain cancer cells and then they can be destroyed by radiation is an achievement in its own right, it's never been done before. As far as the bladder cancer is concerned, they should also use radiation instead of laser since laser misses quite a few deeper cells, I'm sure
Comment by O12009 on Oct 03, 2023 2:06pm
All in time
Comment by FGPstock on Oct 03, 2023 2:25pm
  does anyone know of a us online broker that allows me to buy Canadian warrants on the tax? I have accounts w Ameritrade/Schwab, E*trade and interactive brokers and non of them allow it. 
Comment by Rumpl3StiltSkin on Oct 03, 2023 2:33pm
I bought mine through Fidelity. Need to talk to their international desk by phone to place the orders. Remember, you can't exercise them as a US person, only trade them. Also, the fees are steep. GL
Comment by Rumpl3StiltSkin on Oct 03, 2023 3:30pm
Oh and yeah, setting up a Fidelity account online, went smooth including  funding. But you have to setup the account that has access to international stock trading.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250